LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Respiratory Pathogen Diagnostic Panel Now Certified for Use in Europe

By LabMedica International staff writers
Posted on 03 Nov 2015
Print article
Image: The NxTAG Respiratory Pathogen Panel simultaneously detects 21 respiratory pathogens in a single closed tube system (Photo courtesy of Luminex Corporation).
Image: The NxTAG Respiratory Pathogen Panel simultaneously detects 21 respiratory pathogens in a single closed tube system (Photo courtesy of Luminex Corporation).
European certification (CE marking) has been granted for a diagnostic panel that incorporates tests for 21 clinically-relevant viral and bacterial respiratory pathogens into a single closed microtiter plate well.

The wide range of the Luminex Corporation (Austin, TX, USA) NxTAG Respiratory Pathogen Panel also includes such atypical bacteria as Chlamydophila pneumoniae, Mycoplasma pneumoniae, and Legionella pneumophila.

The NxTAG panel was designed for use with the Luminex MAGPIX instrument, which operates with fluorescent markers and magnetic microbeads. Each sample to be tested requires only minutes of hands-on time with no upstream reagent preparation. Simplified workflow allows extracted samples to be added directly to pre-plated, lyophilized reagents. The wells are then sealed and ready for closed tube amplification and subsequent detection using the Luminex MAGPIX instrument. Innovative tube strip design offers laboratories the flexibility to manage variable sample demand by processing a single sample or up to as many as 96 samples per run, without wasting consumables or reagents, or the need to have full batches. Total turnaround time is just over three hours for 96 samples.

Onboard SYNCT Software provides a comprehensive approach to data analysis and reporting, and enables the NxTAG Respiratory Pathogen Panel to integrate easily into any laboratory setting.

"As a leader in multiplexed solutions, we are excited to launch the next generation NxTAG Respiratory Pathogen Panel which delivers expanded coverage and a simple closed tube workflow, combined with the throughput and quality of results established by the xTAG Respiratory Viral Panel," said Thomas Pracht, Managing Director, EMEIA (Europe, Middle East, India, and Africa), at Luminex Corporation. "With the CE-IVD marking of the NxTAG Respiratory Pathogen Panel, we continue to focus on delivering solutions that address our customers' productivity needs."

Related Links:
Luminex Corporation

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
ACTH Assay
ACTH ELISA
New
Coagulation Analyzer
CS-2400

Print article

Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Sekisui Diagnostics UK Ltd.